[
    [
        {
            "time": "",
            "original_text": "[推荐评级]医药生物行业深度研究报告：寻找“红海”中的“蓝海”-中外仿制药定价与销售深度报告",
            "features": {
                "keywords": [
                    "医药生物",
                    "仿制药",
                    "定价",
                    "销售",
                    "红海",
                    "蓝海"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "[推荐评级]医药生物行业深度研究报告：寻找“红海”中的“蓝海”-中外仿制药定价与销售深度报告",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]